Thousand Oaks-based biotech Amgen filed a lawsuit alongside other pharma heavyweights and an advertising industry association that aims to strike down a new federal rule requiring them to put drug pricing information in their television advertisements. The rule, which goes into effect July 9, would mislead patients about their out-of-pocket costs, the suit alleges. It…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
